This week from Drug Target Review...
A study led by scientists from the Center for Genetic Epidemiology at the Keck School of Medicine of USC and USC Norris Comprehensive Cancer Center has made a significant leap in our understanding of aggressive prostate cancer.
TRENDING THIS WEEK
Researchers pinpoint connections of risk variants with microglia functions that are important for Alzheimer’s disease (AD). Read more>>>
Researchers have achieved profound insights into the inner workings of a prevalent environmental bacterium. Read more>>>
New research improves patient care by finding where gene copies integrate into DNA and using lentiviral vectors.?Read more>>>
A novel treatment approach using DON molecule starves tumours of essential nutrient, significantly slowing tumour growth. Read more>>>
WHAT TO LISTEN TO
Tune into?our latest podcasts?which are curated with researchers and scientific leaders in mind. We sit down with industry experts and dive into the latest trends, research and innovation in drug discovery and early-phase therapeutic development.
领英推荐
Listen to our episodes?as we discuss topics such as multiplexed imaging, complex assays and organoids.
All caught up? Follow us on?Spotify,?Apple?and?Google Podcasts?to get notified when our next episode is live!
===
WHAT TO WATCH
Discover the latest trends and innovations in drug discovery with our range of?expert-led webinars.
Our?FREE one-hour sessions?cover a wide variety of topics, from the basics of drug discovery to the latest cutting-edge technologies and techniques. Whether you're a seasoned researcher or just starting out, our webinars offer valuable insights and practical advice to help you stay ahead of the curve.
Don't miss out on the opportunity to enhance your knowledge and skills.
===
SIGN UP FOR FREE
Stay connected with the most pressing topics and trends in global drug discovery and early-phase therapeutic development.
Drug Target Review?is an essential multimedia resource for researchers and scientific leaders covering the latest innovation and cutting-edge technological progression in the industry.?Sign up for FREE access to breaking news, thought leadership and expert insights.?
Want to keep up to date with our latest content? Follow us on?LinkedIn,?Facebook,?Twitter?and?YouTube.
Get involved in the conversation?#DTRTalks
https://www.drugtargetreview.com/news/111980/pancreatic-tumours-fooled-by-glutamine-mimic/ Pancreatic #cancer has one of the lowest survival rates among cancers. Most people only live three to six months after being diagnosed with the disease.